Oecona AS provides services within health economic modelling and analysis, market access strategies and health policy-oriented analysis. Oecona has more than 20 years of experience operating in these markets. The market access environment in the Nordic countries is steadily changing, and Oecona gives guidance on how to effectively interact with the various governmental decision makers when a new product or indication shall be launched.

Gaining market access for pharmaceuticals and medical devices in the Nordics requires insight in both regulation, the roles of the various governmental bodies, as well as health economics and governmental affairs.

In Oecona we have many years of experience from the pharmaceutical industry in both Norwegian, Swedish and Nordic roles. Advanced health economic models and HTA dossiers developed by Oecona employees have secured reimbursements and hospital financing for drugs within therapeutic areas such as CV, Oncology, Respiratory, CNS and orthopedics.